The OTC department participated in the Lebanese International Fertility Summit 2025, where they showcased the full Clearblue portfolio, with a special focus on the Clearblue Ovulation Test and Clearblue Digital Test.


The event provided an opportunity to reinforce the company's presence in the fertility field and strengthen relationships with healthcare professionals.

A key highlight was the Clearblue Symposium, led by Dr. Elie Snaifer, gynecologist, who discussed ART in PCOS and emphasized that Clearblue ovulation testing is the first step for couples wishing to conceive.
The symposium reinforced Clearblue's role as the first step before advancing to more complex fertility treatments, helping physicians guide their patients with confidence.